Related Experiment Videos
Ursodeoxycholic acid therapy in primary biliary cirrhosis
M Podda1, A Crosignani, P M Battezzati
1Cattedra di Medicina Interna, Università di Milano, Italy.
The Italian Journal of Gastroenterology
|February 1, 1996
Summary
Ursodeoxycholic acid
Area of Science:
- Hepatology
- Clinical Pharmacology
Background:
- Primary biliary cirrhosis (PBC) is a chronic liver disease.
- Current therapeutic options for PBC have limitations.
Purpose of the Study:
- To review the current literature on ursodeoxycholic acid (UDCA) for PBC treatment.
- To identify challenges in assessing UDCA's efficacy in PBC.
Main Methods:
- Literature review of ursodeoxycholic acid in primary biliary cirrhosis treatment.
- Analysis of difficulties in establishing therapeutic efficacy.
Main Results:
- Establishing the efficacy of ursodeoxycholic acid in primary biliary cirrhosis is challenging.
- Existing studies face limitations in demonstrating clear clinical benefits.
Conclusions:
- Further research is required to confirm ursodeoxycholic acid's role in primary biliary cirrhosis.
- Updated meta-analyses incorporating ongoing trials are necessary.